We provide guidance regarding the design of clinical studies and cost-effectiveness analyses necessary to obtain regulatory approval and to secure coverage by various payers.

We work with our clients to help ensure that clinical studies performed to secure FDA clearance will also be useful in seeking coverage by public and private payers. Increasingly, FDA clearance alone is insufficient for many product categories to ensure coverage from U.S. payers. 

A number of our professionals have clinical backgrounds, providing us with the ability to address, understand and articulate complex clinical arguments quickly, and enabling us to anticipate and address clinical arguments involved in the strength of clinical literature and other relevant data collection issues.